FC

Fahad Chembakasseri

Active Director Designated Partner DIN 10930128
DIN 10930128 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Fahad Chembakasseri

Data last updated:

Fahad Chembakasseri is a Designated Partner at Marf Healthcare Llp (since 2025).

DIN 10930128
Primary Designation Designated Partner
First Appointment 29 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Jan 20252025Active

Board colleagues of Fahad Chembakasseri

NameDINCompanyDesignation
Abdul Manaf10930131Marf Healthcare LlpDesignated Partner
Anju Kunnanchery Pannikkattullam10930130Marf Healthcare LlpDesignated Partner
Riyasali Unniyakkal10930129Marf Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Marf Healthcare Llp
Premium access

Shareholding and investment profile for Fahad Chembakasseri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fahad Chembakasseri

Fahad Chembakasseri currently holds 1 directorship: Marf Healthcare Llp (Designated Partner, since 29 Jan 2025).

Fahad Chembakasseri was first appointed on 29 Jan 2025 as Designated Partner at Marf Healthcare Llp.

The current boards of Fahad Chembakasseri's companies include Abdul Manaf (Marf Healthcare Llp), Anju Kunnanchery Pannikkattullam (Marf Healthcare Llp), Riyasali Unniyakkal (Marf Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available